Rima F. Jubran

Hematology | Oncology
4650 W Sunset Blvd
Los Angeles, CA 90027

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.

Clofarabine for relapsed/refractory LCH and non-LC histiocytosis.

Journal: Blood advances
Published: February 11, 2026

Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.

Clofarabine for relapsed/refractory Langerhans cell (LC) and non-LC histiocytosis.

Journal: Blood advances
Published: February 11, 2026

Saving the Eye, Counting the Cost: Rethinking Treatment Burden in Unilateral Retinoblastoma.

Saving the Eye, Counting the Cost: Rethinking Treatment Burden in Unilateral Retinoblastoma.

Journal: Clinical & experimental ophthalmology
Published: January 27, 2026

Prospective implementation of an aqueous humor liquid biopsy platform informs clinical diagnosis and management of retinoblastoma and other intraocular lesions.

Prospective implementation of an aqueous humor liquid biopsy platform informs clinical diagnosis and management of retinoblastoma and other intraocular lesions.

Journal: NPJ precision oncology
Published: September 06, 2025

The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence.

The use of aqueous humor cfDNA for low-pass whole genome sequencing as a clinical test to identify intraocular retinoblastoma recurrence.

Journal: ScienceBank
Published: January 01, 2025

Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study.

Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study.

Journal: The British journal of ophthalmology
Published: November 09, 2024

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.

Journal: Cancer
Published: January 16, 2024

A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).

A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1).

Journal: Pediatric blood & cancer
Published: May 22, 2023

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).

Intensive Multimodality Therapy for Extraocular Retinoblastoma: A Children's Oncology Group Trial (ARET0321).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 12, 2022

Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.

Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.

Journal: Ophthalmology
Published: March 19, 2022

High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.

High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.

Journal: Ophthalmology
Published: January 30, 2022

Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.

Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.

Journal: The British journal of ophthalmology
Published: January 21, 2021
Showing 1-12 of 55

Last Updated: 09/26/2026